Abstract: An anastomosis device and related methods for performing an anastomosis procedure, such as rejoining a urethra with a bladder following a radical prostatectomy. The engagement structures each have deployable tines for grasping the tissue proximate to the end of the biological lumen and the opening in the bodily organ. The anastomosis device also has a positioning apparatus for dynamically maintaining the engagement structures in proximity throughout a healing process such that tissue to be joined remains in approximation.

Abstract: Described are devices useful to inject fluid to tissue without the use of a needle, and related methods; the devices include one or a combination of features such as ejection orifices, distal end control features, or combinations of these; the systems can include a fluid delivery system having an injector source and an access device; the access device can comprise a minimally invasive, tubular delivery lumen such as a catheter or endoscope; the tube-like device further includes one or more apposing jets that are selectively fired to force the injection orifice of the tube-like device against the target tissue; selective firing can include a continuous firing during the injection to improve the efficiency of the treatment.

Abstract: Described are needleless injection systems and methods that involve features including one or more of a tissue tensioner and a fitting that includes or attaches to a shaft, exemplary embodiments including: an elastic sleeve sized to fit under tension about the distal end of a flexible scope, such as an endoscope; a non-metal, polymeric tube-like device being optionally attached to the elastic sleeve for delivering a therapeutic fluid to a treatment site within a patient wherein the elastic sleeve may include an integral balloon (tissue tensioner) feature that can be used to position the injection orifice of the tube-like device proximate a treatment area.

Abstract: A needleless fluid delivery system allowing for selective control of amounts of therapeutic fluids that are administered to treatment sites within a patient. The fluid delivery system includes an injector source and an access device. The fluid delivery system generally includes an adjustable volume control system for selectively metering the amount of therapeutic fluid to be delivered to the treatment location. The adjustable volume control system generally includes a mechanical stop system with a plunger member and a stop member, wherein the plunger member and stop member physically interact to restrict a plunger insertion length which simultaneously controls an amount of therapeutic fluid expelled by said plunger.

Abstract: A medical device includes a coil having a longitudinal axis and a radial axis orthogonal to the longitudinal axis, formed from a wire. The wire includes a cross-section with a centroid, a moment of inertia with respect to an axis running through the centroid and parallel to the longitudinal axis of the coil, and a moment of inertia with respect to an axis running through the centroid and parallel to the radial axis of the coil. The moment of inertia with respect to an axis running through the centroid and parallel to the longitudinal axis of the coil is greater than the moment of inertia with respect to an axis running through the centroid and parallel to the radial axis of the coil.

Abstract: Described are devices useful to deliver fluid to tissue of the bladder, bladder neck, prostate, urethra, ureter, kidney, and related methods, the devices including one or a combination of features such as a steerable shaft, an optical mechanism, multiple fluid delivery orifices that may be moveable or extendable laterally, longitudinally, or distally; the methods allowing for delivery of one or multiple types of fluid to tissue such as the bladder (including the bladder neck), urethra, prostate, kidney, ureter, etc.

Abstract: A non-metal, polymeric tubular device for delivering a therapeutic fluid to a treatment site within a patient. The non-metal, polymeric tubular device can be fabricated using suitable high strength polymers and in some versions can be reinforced through the inclusion of reinforcement materials or braiding. The non-metal, polymeric tubular device can be fabricated so as to have a burst strength exceeding at least about 2,000 psi. The non-metal, polymeric tubular device can be fabricated so as to have distention properties, wherein an orifice or jet port located at a distal end of the polymeric tubular device retains its shape and/or size without suffering swelling that can have a detrimental impact on a fluid jet used to deliver the therapeutic fluid at the treatment site.

Abstract: A needleless fluid delivery system allowing for selective control of amounts of therapeutic fluids that are administered to treatment sites within a patient. The fluid delivery system includes an injector source and an access device. The fluid delivery system generally includes an adjustable volume control system for selectively metering the amount of therapeutic fluid to be delivered to the treatment location. The adjustable volume control system generally includes a mechanical stop system with a plunger member and a stop member, wherein the plunger member and stop member physically interact to restrict a plunger insertion length which simultaneously controls an amount of therapeutic fluid expelled by said plunger.

Abstract: An elongate medical device such as a guidewire, that may comprise a first elongate member having a proximal end, a distal end and a lumen there between, a second elongate member having a proximal end and a distal end, the second elongate member at least partially disposed in the first elongate member, a first connection between first elongate member and the second elongate member at the proximal end of the first elongate member, a second connection between the first elongate member and the second elongate member at the distal end of the first elongate member, and a third connection between the first elongate member and the second elongate member, the third connection disposed at a point between the first connection and the second connection, wherein the third connection is substantially at a location selected by the Method for Enhancing the Ratio of Torsional Stiffness to Transverse Flexibility.

Abstract: Methods of selectively treating linear elastic materials to produce localized areas of superelasticity and/or shape-memory are disclosed. In an illustrative method, a linear elastic workpiece may be formed into a particular shape by cold-forming or other low-temperature process, and incorporated into a medical device such as an embolic protection filter, vena cava filter, stent or guidewire. A heat source may be used to apply thermal energy to selective areas of the workpiece, imparting superelasticity to the material.

Abstract: A system for connecting a compatibility liner with a source of perishable therapeutic is provided. In one exemplary system for connecting a reservoir of perishable therapeutic with a lumen, a hollow hub having a first end and a second end is provided. The first end of the hollow hub, which contains a bond port, is in fluid communication with the second end. The second end of the hollow hub may contain a docking groove that is sized to couple a reservoir to it. The system also includes an inner hypo-tube having a proximal tip and an inner lumen. This inner lumen is lined with a therapeutic compatible lining and is in fluid communication with the second end of the hub through the proximal tip of the inner hypo-tube. The inner lining and the proximal tip in this system are configured to shield therapeutic ejected from the reservoir from contacting materials that can diminish the integrity of the therapeutic.

Abstract: A flexible cytoscope having an injection device with a cross-sectional profile allowing for irrigation flow without the risk of buckling or lateral deflection of the injection device. The cross-sectional profile is configured such that the injection device is constrained by the cytoscope lumen. The cross-sectional profile of the injection device can be formed integrally with the injection device or can alternatively comprise a secondary structure that is attached about an exterior portion of the injection device. The cross-sectional profile can be present at intervals along the length of the injection device or can extend the entire length of the injection device. The injection device can be configured such that the cross-sectional profile centers the injection device within the cytoscope lumen or in an off-set or non-centered position depending upon the treatment being performed.

Abstract: An improved catheter design for use in visualizing the prostate. The catheter includes an imaging balloon and a bladder retention balloon. The imaging balloon is disposed along the catheter proximate the location of the prostate. An actuator mechanism is operably connected to the imaging balloon so that the operator can selective inflate/deflate the imaging balloon to correspond with treatment or an ultrasound procedure. The actuator mechanism will allow for various inflation and deflation settings.

Abstract: A non-metal, polymeric tubular device for delivering a therapeutic fluid to a treatment site within a patient. The non-metal, polymeric tubular device can be fabricated using suitable high strength polymers and in some versions can be reinforced through the inclusion of reinforcement materials or braiding. The non-metal, polymeric tubular device can be fabricated so as to have a burst strength exceeding at least about 2,000 psi. The non-metal, polymeric tubular device can be fabricated so as to have distention properties, wherein an orifice or jet port located at a distal end of the polymeric tubular device retains its shape and/or size without suffering swelling that can have a detrimental impact on a fluid jet used to deliver the therapeutic fluid at the treatment site.

Abstract: An endoscope adapter ring for a needleless fluid delivery system for delivering therapeutic fluids to treatment sites within a patient. The needless fluid delivery system can include an automated injector source and a needleless access device. The access device can include a delivery scope and a treatment specific applicator. The adapter ring is operably attached to the endoscope to keep the injector lumen in a known orientation for the use of a side injector.

Abstract: Devices, methods and systems for delivering drugs and therapeutic fluids to the prostate without requiring piercing of the prostate. An infusion catheter includes at least two inflatable balloons including a distal balloon providing a seal between the bladder and the prostatic urethra as well as a proximal balloon for sealing off the prostatic urethra from the penal urethra. The infusion catheter can include a number of lumens such as, for example, a drug delivery lumen, a drainage lumen, and one or more inflation lumens. The infusion catheter can have one or more drug delivery ports located between the distal balloon and the proximal balloon, wherein each drug delivery port is in fluid communication with the drug delivery lumen. In addition, the catheter can include one or more intermediate balloons at selected locations between the proximal balloon and the distal balloon for isolating portions of the prostate from exposure to treatment.

Abstract: A method for connecting a compatibility liner with a source of perishable therapeutic is provided. In one exemplary system for connecting a reservoir of perishable therapeutic with a lumen, a hollow hub having a first end and a second end is provided. The first end of the hollow hub, which contains a bond port, is in fluid communication with the second end. The second end of the hollow hub may contain a docking groove that is sized to couple a reservoir to it. The system also includes an inner hypo-tube having a proximal tip and an inner lumen. This inner lumen is lined with a therapeutic compatible lining and is in fluid communication with the second end of the hub through the proximal tip of the inner hypo-tube. The inner lining and the proximal tip in this system are configured to shield therapeutic ejected from the reservoir from contacting materials that can diminish the integrity of the therapeutic.

Abstract: An embolic protection filter device having a filtering membrane, an integrally formed waist, and a flexible hoop affixed to the filtering membrane by melt bonding. A method of making filtering membranes for an embolic protection filter device comprising blow molding the filtering membranes. A method of making an embolic protection filter device comprising blow molding a filtering membrane and simultaneously melt bonding a flexible hoop to the filtering membrane.

Abstract: Method and apparatus for connecting a compatibility liner with a source of perishable therapeutic is provided. In one exemplary system for connecting a reservoir of perishable therapeutic with a lumen, a hollow hub having a first end and a second end is provided. The first end of the hollow hub, which contains a bond port, is in fluid communication with the second end. The second end of the hollow hub may contain a docking groove that is sized to couple a reservoir to it. The system also includes an inner hypo-tube having a proximal tip and an inner lumen. This inner lumen is lined with a therapeutic compatible lining and is in fluid communication with the second end of the hub through the proximal tip of the inner hypo-tube. The inner lining and the proximal tip in this system are configured to shield therapeutic ejected from the reservoir from contacting materials that can diminish the integrity of the therapeutic.

Abstract: An apparatus for connecting a compatibility liner with a source of perishable therapeutic is provided. In one exemplary system for connecting a reservoir of perishable therapeutic with a lumen, a hollow hub having a first end and a second end is provided. The first end of the hollow hub, which contains a bond port, is in fluid communication with the second end. The second end of the hollow hub may contain a docking groove that is sized to couple a reservoir to it. The system also includes an inner hypo-tube having a proximal tip and an inner lumen. This inner lumen is lined with a therapeutic compatible lining and is in fluid communication with the second end of the hub through the proximal tip of the inner hypo-tube. The inner lining and the proximal tip in this system are configured to shield therapeutic ejected from the reservoir from contacting materials that can diminish the integrity of the therapeutic.